NCT04091373View on ClinicalTrials.gov

A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 27, 2019

Primary Completion Date

March 6, 2020

Study Completion Date

March 6, 2020

Conditions
Type 2 Diabetes Mellitus
Interventions
COMBINATION_PRODUCT

cotadutide multidose pen injection

SC injection in the upper arm

COMBINATION_PRODUCT

cotadutide multidose pen injection

SC injection in the lower abdomen

COMBINATION_PRODUCT

cotadutide multidose pen injection

SC injection in the thigh

Trial Locations (1)

32117

Research Site, Daytona Beach

Sponsors

Lead Sponsor

MedImmune LLC
All Listed Sponsors
lead

MedImmune LLC

INDUSTRY

NCT04091373 - A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide | Biotech Hunter | Biotech Hunter